Clinical Trial

A Study Comparing the Effects of Two Types of Natural Oils Used in a Bedtime Foot Massage Routine on Sleep and Emotional Well-Being in Perimenopausal Women.

Study acronym: BG-SLEEP
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2025 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is being done to find out whether a nightly 5-minute foot massage (Padabhyanga) using Brahmi-Gotukola oil can help women ages 40 to 55 sleep better and feel calmer during perimenopause. Perimenopause is the time when periods start to change and many women begin to experience sleep problems and mood changes. The study will also compare Brahmi-Gotukola oil to organic sesame oil, which will be used as the control oil. Participants will do a simple guided 10-minute foot massage at home every night for 2 weeks using either Brahmi-Gotukola oil or organic sesame oil. They will fill out a short sleep log each morning to track their sleep. Before starting the study and again at the end of the 2-week period, they will complete questionnaires about their sleep and mood. Additional follow-up questionnaires will be completed in the 3rd and 4th weeks to see if any improvements continue even after the massage period is over. This study aims to: See whether Brahmi-Gotukola oil foot massage improves sleep in women experiencing perimenopausal sleep problems. Find out whether Brahmi-Gotukola oil foot massage helps with mood and emotional well-being. Compare Brahmi-Gotukola oil foot massage with sesame oil foot massage to determine whether Brahmi oil provides more benefits for sleep and mood.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Status change: Recruiting → Active, Not Recruiting 2025-12-11
Trial Details
NCT Number NCT07274371
Lead Sponsor Saipriya Gowrishankar
Collaborators: Maharishi International University
Conditions Sleep Disturbances in Perimenopause
Enrollment 30 participants
Start Date 2025-11-06
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-18